A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma

from Cancer via ola Kala on Inoreader http://ift.tt/2u7AGAD
via IFTTT